GMO International Value ETF

GMOI aims for total return by focusing on international equities considered undervalued. The fund employs a combination of quantitative methods to analyze financial data, market conditions, and broader economic trends. Its proprietary models forecast returns by assessing both tangible and intangible company assets. This approach informs portfolio construction by considering sector diversity, geographic exposure, and ESG factors, while avoiding investments in industries like cluster munitions and thermal coal. By maintaining a broad investment strategy, GMOI addresses various market capitalizations and regions. To enhance liquidity and provide flexibility, the fund can also invest in the GMO US Treasury Fund and money market instruments.

GMO International Value ETF trades as GMOI on AMEX. The company is classified in Financial Services / Asset Management - Global and reports in USD.

The current profile places the business in Asset Management - Global. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

GMO International Value ETF can be compared against peers such as WisdomTree Europe SmallCap Dividend Fund, iShares MSCI Denmark ETF, First Trust Mid Cap Value AlphaDEX Fund, iShares US & Intl High Yield Corp Bond ETF, iShares Currency Hedged MSCI Emerging Markets ETF, Counterpoint High Yield Trend ETF.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $243.48M, beta of 0.18, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

GMOI currently shows total debt of N/A and beta of 0.18. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.gmo.com/americas/product-index-page/equities/international-opportunistic-value-strategy/international-value-etf/

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.